Paul, Weiss, Rifkind, Wharton & Garrison LLP

Paul, Weiss, Rifkind, Wharton & Garrison LLP handles the full spectrum of tech and life sciences patent disputes, spanning jury and bench trials as well as appeals at the Federal Circuit. The department is further distinguished by its ‘top-notch’ antitrust and trade secret offering. In New York, the team is co-chaired by Brad Karp, Jessica Carey and Catherine Nyarady. Nyardy is a prominent patent litigator with expertise in medical devices, semiconductors and pharma. In Washington DC, Kannon Shanmugam, a leading appellate litigator, chairs the team. Elizabeth Stotland Weiswasser frequently takes on the role of lead counsel in high-stakes pharma and biotech patent disputes, while Katherine Forrest handles patent and antitrust litigation related to AI, cryptocurrency and blockchain. Crystal Parker brings valuable expertise in Hatch-Waxman litigation, biologics and medical devices. Additionally, Kripa Raman further strengthens the team’s capabilities with his experience in patent and trade secret litigation. Karen Dunn, Bill Isaacson, and Jeannie S. Rhee have departed the firm.